Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.46)
# 431
Out of 5,090 analysts
22
Total ratings
66.67%
Success rate
18.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.58 | +312.19% | 2 | Dec 3, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $25 | $7.92 | +215.66% | 1 | Nov 24, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $10 → $7 | $1.08 | +548.15% | 1 | Nov 13, 2025 | |
| TERN Terns Pharmaceuticals | Upgrades: Buy | $20 | $29.36 | -31.88% | 1 | Nov 4, 2025 | |
| SNDX Syndax Pharmaceuticals | Reiterates: Buy | $40 | $20.32 | +96.85% | 2 | Oct 27, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $10.24 | +290.63% | 2 | Oct 20, 2025 | |
| MRUS Merus | Downgrades: Neutral | $135 → $97 | $96.14 | +0.89% | 1 | Sep 30, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $23 | $5.33 | +331.52% | 1 | Sep 29, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $70 → $105 | $80.38 | +30.63% | 2 | Sep 29, 2025 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $50 → $44 | $45.02 | -2.27% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $43.30 | +73.21% | 3 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $8.07 | +209.79% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.29 | +249.34% | 1 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.43 | +242.15% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $21.69 | -7.79% | 1 | Aug 8, 2025 |
Protara Therapeutics
Dec 3, 2025
Reiterates: Buy
Price Target: $23
Current: $5.58
Upside: +312.19%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $25
Current: $7.92
Upside: +215.66%
TScan Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $10 → $7
Current: $1.08
Upside: +548.15%
Terns Pharmaceuticals
Nov 4, 2025
Upgrades: Buy
Price Target: $20
Current: $29.36
Upside: -31.88%
Syndax Pharmaceuticals
Oct 27, 2025
Reiterates: Buy
Price Target: $40
Current: $20.32
Upside: +96.85%
Corbus Pharmaceuticals Holdings
Oct 20, 2025
Reiterates: Buy
Price Target: $40
Current: $10.24
Upside: +290.63%
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $96.14
Upside: +0.89%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.33
Upside: +331.52%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $80.38
Upside: +30.63%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $45.02
Upside: -2.27%
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $43.30
Upside: +73.21%
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $8.07
Upside: +209.79%
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $6.43
Upside: +242.15%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $21.69
Upside: -7.79%